Find your path to Scott
Sign up to see every warm intro you have to Scott
- Paths you didn't know you had: your email and LinkedIn already hold routes to Scott. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Martin is a private investor and former Chair of the NBDF Board whose son has severe hemophilia. He co-founded Inspiration Biopharmaceutical and Martin Midstream Partners (NASDAQ: MMLP).
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Haiyan Jiang
Scientific Advisory Group Member at Pathway to Cures
Frequently asked questions
- Who is Scott Martin?
- Martin is a private investor and former Chair of the NBDF Board whose son has severe hemophilia. He co-founded Inspiration Biopharmaceutical and Martin Midstream Partners (NASDAQ: MMLP).
- Where does Scott Martin work?
- Scott Martin is P2C Board Chair at Pathway to Cures.
About this profile. Compiled from public sources — Pathway to Cures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights








